05/13/2026
From B2C to B2B2C: Accelerating Our Path to Scale
When we started Allerbi, we set out to help people stay fit and healthy through fun, engaging experiences. Our direct-to-consumer (B2C) tests — including Meta ad campaigns with a 4.94% CTR — confirmed strong consumer demand.
But to achieve our true ambition of reaching millions, not thousands, we realized a better path.
Today, we are announcing a strategic shift: Allerbi is moving from B2C to a B2B2C model.
Our vertically integrated platform — combining content, software, and proprietary resistance algorithms — is now designed to integrate directly into OEM products. Think: smart bikes, treadmills, rowers, and other fitness devices from brands you already trust.
Why the change?
Scale: One OEM partnership can reach more users than years of D2C marketing.
Impact: By embedding into existing products, we remove friction and make fitness accessible to everyone, everywhere.
Focus: We do what we do best (science, algorithms, experiences) while partners do what they do best.
We are already in active discussions with OEM partners, expect our first pilot signed in Q3 2026, and anticipate first revenue in Q4 2026.
Our mission hasn't changed. Our model has — for the better.
To our early B2C supporters: thank you. You proved the demand. Now, we're building the supply chain to match.
To OEM partners: let's talk. Your hardware + our platform = better fitness for everyone. It is a win-win.